| HOME >> BIOLOGY >> TECHNOLOGY |
-------------------------------------------------------------------------
Loss and comprehensive loss
for the period (2,761,874) (1,469,728) (29,581,295)
Deficit, beginning of period (26,819,421) (16,383,139) -
-------------------------------------------------------------------------
Deficit, end of period (29,581,295) (17,852,867) (29,581,295)
-------------------------------------------------------------------------
-------------------------------------------------------------------------
Loss per share - basic and diluted (0.06) (0.03)
-------------------------------------------------------------------------
-------------------------------------------------------------------------
Weighted average common shares
outstanding 44,750,964 44,076,383
-------------------------------------------------------------------------
-------------------------------------------------------------------------
ARIUS RESEARCH INC.
(a Development Stage Company)
INTERIM STATEMENTS OF CASH FLOWS
(Unaudited)
------------------------------------------------------------
Nine-month Nine-month
period ended period ended
August 31, August 31,
2007 2006
$ $
------------------------------------------------------------
Cash provided by (used in):
Operating activities:
Loss for the period (8,104,701) (2,820,462)
Items not involving cash:
Amortization of:
Property and equipment 274,630 171,636
Defe
'/>"/>
| SOURCE ARIUS Research Inc. Copyright©2007 PR Newswire. All rights reserved |